BMRN vs GBX · P/E 40, rev $1.76B vs P/E 7.6, rev $3.24B
Biomarin Pharmaceutical Inc (BMRN) versus Greenbrier Companies Inc (GBX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Greenbrier Companies Inc (GBX) is a railroads company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GBX revenue for 2025-08-31 was $3.24B. Net income was $213.1M. GBX currently screens at market cap $1.66B and trailing P/E 7.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GBX currently screens at market cap $1.66B and trailing P/E 7.6.
Not investment advice. Open the BMRN and GBX stock pages for the full models.
Not investment advice.